Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Schizophrenia

  Free Subscription


Articles published in Am J Psychiatry

Retrieve available abstracts of 50 articles:
HTML format
Text format



Single Articles


    November 2018
  1. BERGEN SE, Ploner A, Howrigan D, O'Donovan MC, et al
    Joint Contributions of Rare Copy Number Variants and Common SNPs to Risk for Schizophrenia.
    Am J Psychiatry. 2018 Nov 5:appiajp201817040467.
    PubMed     Text format     Abstract available


  2. ZHANG JP, Robinson D, Yu J, Gallego J, et al
    Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis.
    Am J Psychiatry. 2018 Nov 5:appiajp201817121363.
    PubMed     Text format     Abstract available


    October 2018
  3. MARTINEZ A, Gaspar PA, Hillyard SA, Andersen SK, et al
    Impaired Motion Processing in Schizophrenia and the Attenuated Psychosis Syndrome: Etiological and Clinical Implications.
    Am J Psychiatry. 2018 Oct 3:appiajp201818010072.
    PubMed     Text format     Abstract available


    September 2018
  4. ZHANG T, Li H, Tang Y, Niznikiewicz MA, et al
    Validating the Predictive Accuracy of the NAPLS-2 Psychosis Risk Calculator in a Clinical High-Risk Sample From the SHARP (Shanghai At Risk for Psychosis) Program.
    Am J Psychiatry. 2018;175:906-908.
    PubMed     Text format    


    August 2018
  5. XIAO Y, Sun H, Shi S, Jiang D, et al
    White Matter Abnormalities in Never-Treated Patients With Long-Term Schizophrenia.
    Am J Psychiatry. 2018 Aug 2:appiajp201817121402.
    PubMed     Text format     Abstract available


  6. VERMEULEN JM, Schirmbeck F, Blankers M, van Tricht M, et al
    Association Between Smoking Behavior and Cognitive Functioning in Patients With Psychosis, Siblings, and Healthy Control Subjects: Results From a Prospective 6-Year Follow-Up Study.
    Am J Psychiatry. 2018 Aug 2:appiajp201818010069.
    PubMed     Text format     Abstract available


  7. KAHN RS
    On the Continued Benefit of Antipsychotics After the First Episode of Schizophrenia.
    Am J Psychiatry. 2018;175:712-713.
    PubMed     Text format    


    July 2018
  8. KRIVINKO JM, Erickson SL, Ding Y, Sun Z, et al
    Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease.
    Am J Psychiatry. 2018 Jul 19:appiajp201817080858.
    PubMed     Text format     Abstract available


    June 2018
  9. EL-MALLAKH RS, Furdek C
    Cycloid Psychosis.
    Am J Psychiatry. 2018;175:502-505.
    PubMed     Text format    


    May 2018
  10. NELSON JC, Bickford D, Delucchi K, Fiedorowicz JG, et al
    Risk of Psychosis in Recurrent Episodes of Psychotic and Nonpsychotic Major Depressive Disorder: A Systematic Review and Meta-Analysis.
    Am J Psychiatry. 2018 May 24:appiajp201817101138.
    PubMed     Text format     Abstract available


  11. FARRELL M, Lichtenstein M, Crowley JJ, Filmyer DM, et al
    Developmental Delay, Treatment-Resistant Psychosis, and Early-Onset Dementia in a Man With 22q11 Deletion Syndrome and Huntington's Disease.
    Am J Psychiatry. 2018;175:400-407.
    PubMed     Text format    


  12. ROSENHECK R
    Toward Dissemination of Secondary Prevention for Psychosis.
    Am J Psychiatry. 2018;175:393-394.
    PubMed     Text format    


    April 2018
  13. TIIHONEN J, Tanskanen A, Taipale H
    20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia.
    Am J Psychiatry. 2018 Apr 6:appiajp201817091001.
    PubMed     Text format     Abstract available


  14. JEZEQUEL J, Lepleux M, Kahn RS, Honnorat J, et al
    Molecular Pathogenicity of Anti-NMDA Receptor Autoantibody From Patients With First-Episode Psychosis.
    Am J Psychiatry. 2018;175:382-383.
    PubMed     Text format    


  15. GHOSE S
    Substance-Induced Psychosis: An Indicator of Development of Primary Psychosis?
    Am J Psychiatry. 2018;175:303-304.
    PubMed     Text format    


    March 2018
  16. ANDERSON KK, Norman R, MacDougall A, Edwards J, et al
    Effectiveness of Early Psychosis Intervention: Comparison of Service Users and Nonusers in Population-Based Health Administrative Data.
    Am J Psychiatry. 2018 Mar 2:appiajp201717050480.
    PubMed     Text format     Abstract available


  17. KAUPPI K, Rosenthal SB, Lo MT, Sanyal N, et al
    Revisiting Antipsychotic Drug Actions Through Gene Networks Associated With Schizophrenia.
    Am J Psychiatry. 2018 Mar 2:appiajp201717040410.
    PubMed     Text format     Abstract available


  18. NOORDSY DL, Burgess JD, Hardy KV, Yudofsky LM, et al
    Therapeutic Potential of Physical Exercise in Early Psychosis.
    Am J Psychiatry. 2018;175:209-214.
    PubMed     Text format    


    February 2018
  19. PAYNE JL
    The Psychoses of Menstruation and Childbearingby Ian Brockington, M.D., F.R.C.P. Cambridge, England, Cambridge University Press, 2017, 391 pp., $140.00 (hardcover).
    Am J Psychiatry. 2018;175:190-191.
    PubMed     Text format    


  20. GOFF DC
    Optimizing the Pharmacologic Treatment of Individuals With First-Episode Psychosis.
    Am J Psychiatry. 2018;175:101-102.
    PubMed     Text format    


  21. ROBINSON DG, Schooler NR, Correll CU, John M, et al
    Psychopharmacological Treatment in the RAISE-ETP Study: Outcomes of a Manual and Computer Decision Support System Based Intervention.
    Am J Psychiatry. 2018;175:169-179.
    PubMed     Text format     Abstract available


    December 2017
  22. MCGUIRE P, Robson P, Cubala WJ, Vasile D, et al
    Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial.
    Am J Psychiatry. 2017 Dec 15:appiajp201717030325.
    PubMed     Text format     Abstract available


  23. HAMILTON HK, Williams TJ, Ventura J, Jasperse LJ, et al
    Clinical and Cognitive Significance of Auditory Sensory Processing Deficits in Schizophrenia.
    Am J Psychiatry. 2017 Dec 5:appiajp201716111203.
    PubMed     Text format     Abstract available


    November 2017
  24. LIVNY A, Reichenberg A, Fruchter E, Yoffe R, et al
    A Population-Based Longitudinal Study of Symptoms and Signs Before the Onset of Psychosis.
    Am J Psychiatry. 2017 Nov 28:appiajp201716121384.
    PubMed     Text format     Abstract available


  25. STARZER MSK, Nordentoft M, Hjorthoj C
    Rates and Predictors of Conversion to Schizophrenia or Bipolar Disorder Following Substance-Induced Psychosis.
    Am J Psychiatry. 2017 Nov 28:appiajp201717020223.
    PubMed     Text format     Abstract available


  26. GOES FS, Sawa A
    Psychosis Beyond the 22q11.2 Deletion: Do Additional Genetic Factors Play a Role?
    Am J Psychiatry. 2017;174:1027-1029.
    PubMed     Text format    


  27. SCHOOLER NR
    Long-Term Outcomes of Psychosis: Naturalistic Follow-Up After Initial Hospitalization.
    Am J Psychiatry. 2017;174:1030-1031.
    PubMed     Text format    


  28. KOTOV R, Fochtmann L, Li K, Tanenberg-Karant M, et al
    Declining Clinical Course of Psychotic Disorders Over the Two Decades Following First Hospitalization: Evidence From the Suffolk County Mental Health Project.
    Am J Psychiatry. 2017;174:1064-1074.
    PubMed     Text format     Abstract available


  29. VELTHORST E, Fett AJ, Reichenberg A, Perlman G, et al
    The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders.
    Am J Psychiatry. 2017;174:1075-1085.
    PubMed     Text format     Abstract available


    October 2017
  30. KANE JM
    Clozapine Reduces All-Cause Mortality.
    Am J Psychiatry. 2017;174:920-921.
    PubMed     Text format    


  31. RAHMAN T, Ash DM, Lauriello J, Rawlani R, et al
    Misleading Guidance From Pharmacogenomic Testing.
    Am J Psychiatry. 2017;174:922-924.
    PubMed     Text format    


    September 2017
  32. LEVITT JJ, Nestor PG, Levin L, Pelavin P, et al
    Reduced Structural Connectivity in Frontostriatal White Matter Tracts in the Associative Loop in Schizophrenia.
    Am J Psychiatry. 2017 Sep 15:appiajp201716091046.
    PubMed     Text format     Abstract available


    August 2017
  33. SANDOVAL LR, Torous J, Keshavan MS
    Smartphones for Smarter Care? Self-Management in Schizophrenia.
    Am J Psychiatry. 2017;174:725-728.
    PubMed     Text format    


    July 2017
  34. DAVIDSON M, Saoud J, Staner C, Noel N, et al
    Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201717010122.
    PubMed     Text format     Abstract available


  35. BASSETT AS, Lowther C, Merico D, Costain G, et al
    Rare Genome-Wide Copy Number Variation and Expression of Schizophrenia in 22q11.2 Deletion Syndrome.
    Am J Psychiatry. 2017 Jul 28:appiajp201716121417.
    PubMed     Text format     Abstract available


  36. WIMBERLEY T, MacCabe JH, Laursen TM, Sorensen HJ, et al
    Mortality and Self-Harm in Association With Clozapine in Treatment-Resistant Schizophrenia.
    Am J Psychiatry. 2017 Jul 28:appiajp201716091097.
    PubMed     Text format     Abstract available


  37. ANDREASSEN OA
    Diabetes and Schizophrenia-New Findings for an Old Puzzle.
    Am J Psychiatry. 2017;174:616-617.
    PubMed     Text format    


  38. PHILIP NS, Nelson BG, Frohlich F, Lim KO, et al
    Low-Intensity Transcranial Current Stimulation in Psychiatry.
    Am J Psychiatry. 2017;174:628-639.
    PubMed     Text format     Abstract available


  39. SHARMA A, Wolf DH, Ciric R, Kable JW, et al
    Common Dimensional Reward Deficits Across Mood and Psychotic Disorders: A Connectome-Wide Association Study.
    Am J Psychiatry. 2017;174:657-666.
    PubMed     Text format     Abstract available


    June 2017
  40. COYLE JT
    Cortical Pyramidal Neurons Show a Selective Loss of New Synapses in Chronic Schizophrenia.
    Am J Psychiatry. 2017;174:510-511.
    PubMed     Text format    


    May 2017
  41. LEUCHT S, Leucht C, Huhn M, Chaimani A, et al
    Sixty Years of Placebo-Controlled Antipsychotic Drug Trials in Acute Schizophrenia: Systematic Review, Bayesian Meta-Analysis, and Meta-Regression of Efficacy Predictors.
    Am J Psychiatry. 2017 May 25:appiajp201716121358.
    PubMed     Text format     Abstract available


  42. GOFF DC, Falkai P, Fleischhacker WW, Girgis RR, et al
    The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.
    Am J Psychiatry. 2017 May 5:appiajp201716091016.
    PubMed     Text format     Abstract available


  43. HORVITZ-LENNON M, Mattke S, Predmore Z, Howes OD, et al
    The Role of Antipsychotic Plasma Levels in the Treatment of Schizophrenia.
    Am J Psychiatry. 2017;174:421-426.
    PubMed     Text format    


  44. NAKIMULI-MPUNGU E
    Our Most Troubling Madness: Case Studies in Schizophrenia Across Culturesedited by T.M. Luhrmann and Jocelyn Marrow. Oakland, University of California Press, 2016, 304 pp., $29.95 (paperback).
    Am J Psychiatry. 2017;174:490.
    PubMed     Text format    


  45. HAUSER RA, Factor SA, Marder SR, Knesevich MA, et al
    KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia.
    Am J Psychiatry. 2017;174:476-484.
    PubMed     Text format     Abstract available


  46. BOU KHALIL R
    On the Magical Thinking Related to Mental Health in Chad.
    Am J Psychiatry. 2017;174:427-428.
    PubMed     Text format    


    April 2017
  47. ROSENHECK RA, Estroff SE, Sint K, Lin H, et al
    Incomes and Outcomes: Social Security Disability Benefits in First-Episode Psychosis.
    Am J Psychiatry. 2017 Apr 21:appiajp201716111273.
    PubMed     Text format     Abstract available


  48. LAVRETSKY H
    Hallucinations Predict Relapse After Discontinuation of Risperidone in Patients With Alzheimer's Disease and Psychosis or Agitation.
    Am J Psychiatry. 2017;174:307-308.
    PubMed     Text format    


    March 2017
  49. MACDONALD ML, Alhassan J, Newman JT, Richard M, et al
    Selective Loss of Smaller Spines in Schizophrenia.
    Am J Psychiatry. 2017 Mar 31:appiajp201716070814.
    PubMed     Text format     Abstract available


  50. PATERSON C, Wang Y, Hyde TM, Weinberger DR, et al
    Temporal, Diagnostic, and Tissue-Specific Regulation of NRG3 Isoform Expression in Human Brain Development and Affective Disorders.
    Am J Psychiatry. 2017;174:256-265.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: